Free Trial

Horizon Kinetics Medical ETF Rating

$31.50 -0.08 (-0.24%)
Closing price 10/24/2025 03:57 PM Eastern
Extended Trading
$31.60 +0.11 (+0.35%)
As of 10/24/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

MEDX Aggregate Rating

Moderate Buy
2.59

Holdings in MEDX have an aggregate rating of Moderate Buy based on 384 analyst ratings issued in the past year covering 23 companies (82.6% of the portfolio).

MEDX Aggregate Price Target

$31.50
High Prediction$31.50
Average Prediction$31.50
Low Prediction$31.50

Holdings in MEDX have an aggregate price target of $31.50 and a range of $31.50 to $31.50 covering 23 companies (82.6% of the portfolio).

MEDX Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
Moderate Buy
12 Moderate Buy rating(s)
Hold
9 Hold rating(s)
Reduce
1 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Horizon Kinetics Medical ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 23 MEDX Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
15.16%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$825.86
+0.6%
4.9142 of 5 stars
2.68$938.61 13.7%25Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
9.34%
AbbVie Inc. stock logo
ABBV
AbbVie
$228.06
-0.1%
4.6616 of 5 stars
2.74$234.80 3.0%27Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
5.98%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$463.43
-0.1%
4.01 of 5 stars
2.81$466.92 0.8%27Upcoming Earnings
Analyst Forecast
5.15%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$83.29
-0.1%
3.4157 of 5 stars
2.60$86.00 3.3%5Positive News
Analyst Forecast
Short Interest ↓
4.84%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$190.38
-1.1%
4.9165 of 5 stars
2.77$199.05 4.6%26Positive News
Analyst Forecast
4.62%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$70.86
-0.9%
3.3029 of 5 stars
2.80$78.50 10.8%20Analyst Forecast
4.17%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$67.61
+0.6%
2.1873 of 5 stars
2.42$72.59 7.4%19Analyst Forecast
3.95%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$43.84
+0.0%
4.9722 of 5 stars
2.35$57.23 30.5%20Trending News
Upcoming Earnings
Analyst Revision
3.81%
Alkermes plc stock logo
ALKS
Alkermes
$29.80
-0.8%
4.6172 of 5 stars
3.00$42.83 43.7%15Trending News
Upcoming Earnings
Analyst Upgrade
Analyst Revision
3.68%
Amgen Inc. stock logo
AMGN
Amgen
$291.76
-0.4%
4.5795 of 5 stars
2.28$300.94 3.1%18Positive News
Analyst Forecast
3.45%
Pfizer Inc. stock logo
PFE
Pfizer
$24.79
+0.5%
4.9614 of 5 stars
2.39$28.13 13.5%18Positive News
Analyst Forecast
3.10%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$87.54
+0.4%
4.9964 of 5 stars
2.30$104.33 19.2%20Positive News
Upcoming Earnings
Analyst Forecast
2.58%
GSK PLC Sponsored ADR stock logo
GSK
GSK
$43.24
-5.0%
1.7181 of 5 stars
1.88$37.38 -13.6%8News Coverage
Upcoming Earnings
Dividend Cut
Options Volume
Gap Down
2.46%
Biogen Inc. stock logo
BIIB
Biogen
$149.89
-0.1%
4.729 of 5 stars
2.35$180.69 20.5%31Trending News
Upcoming Earnings
Analyst Upgrade
Analyst Revision
2.17%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$577.95
+0.4%
4.8877 of 5 stars
2.79$802.35 38.8%28News Coverage
Positive News
Upcoming Earnings
Analyst Forecast
1.93%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$25.60
-1.1%
4.2126 of 5 stars
2.55$28.47 11.2%20Analyst Forecast
Gap Up
1.41%
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$27.96
-0.9%
3.6143 of 5 stars
2.94$45.92 64.2%16News Coverage
Analyst Forecast
1.35%
Galectin Therapeutics Inc. stock logo
GALT
Galectin Therapeutics
$5.23
+1.9%
0.9302 of 5 stars
2.00$6.00 14.7%2News Coverage
Analyst Forecast
Insider Trade
Gap Up
0.74%
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$5.50
+0.2%
4.3808 of 5 stars
2.67$16.50 200.0%3News Coverage
Upcoming Earnings
Analyst Forecast
0.70%
Lantern Pharma Inc. stock logo
LTRN
Lantern Pharma
$4.08
+10.3%
1.8031 of 5 stars
2.00$25.00 512.7%2News Coverage
Analyst Forecast
Gap Up
0.68%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$3.72
+1.9%
4.3277 of 5 stars
2.14$5.10 37.1%14Analyst Forecast
0.67%
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
$7.88
+0.9%
3.5269 of 5 stars
2.50$22.22 182.0%10Upcoming Earnings
0.67%
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$9.25
-1.3%
4.3092 of 5 stars
2.50$12.33 33.3%10Positive News
Upcoming Earnings
Analyst Forecast
Short Interest ↓

This page (NASDAQ:MEDX) was last updated on 10/26/2025 by MarketBeat.com Staff
From Our Partners